|
顯示項目 428191-428200 / 2348609 (共234861頁)
<< < 42815 42816 42817 42818 42819 42820 42821 42822 42823 42824 > >>
每頁顯示[10|25|50]項目
| 臺北醫學大學 |
2014 |
Fibroblast growth factor receptor 2 overexpression is predictive of poor prognosis in rectal cancer patients receiving neoadjuvant chemoradiotherapy
|
Li, CF;He, HL;Wang, JY;Huang, HY;Wu, TF;Hsing, CH;Lee, SW;Lee, HH;Fang, JL;Huang, WT;Chen, SH. |
| 國家衛生研究院 |
2013-03-06 |
Fibroblast growth factor receptor 2c signaling is required for intestinal cell differentiation in zebrafish
|
Liu, DW;Tsai, SM;Lin, BF;Jiang, YJ;Wang, WP |
| 國立臺灣大學 |
1996 |
Fibroblast growth factor receptor 3 (FGFR3) gene G1138A mutation in Chinese patients with achondroplasia
|
王作仁; 王文炳; 胡務亮; 李明亮; WANG, TSO-REN; WANG, WEN-PING; HWU, WUH-LIANG; LEE, MING-LIANG |
| 臺大學術典藏 |
2020-12-16T02:26:27Z |
Fibroblast growth factor receptor 3 (FGFR3) gene G1138A mutation in Chinese patients with achondroplasia
|
Wang T.-R.;Wang W.-P.;Wuh-Liang Hwu;Lee M.-L.; Wang T.-R.; Wang W.-P.; WUH-LIANG HWU; Lee M.-L. |
| 中山醫學大學 |
2015-04 |
Fibroblast growth factor receptor 4 polymorphism is associated with liver cirrhosis in hepatocarcinoma.
|
MJ, Sheu; MJ, Hsieh; WL, Chiang; SF, Yang; HL, Lee; LM, Lee; CB, Yeh |
| 臺大學術典藏 |
2021-05-13T03:03:42Z |
Fibroblast Growth Factor Receptor Inhibitors Reduce Adipogenesis of Orbital Fibroblasts and Enhance Myofibroblastic Differentiation in Graves Orbitopathy
|
Shih S.-R.; Liao S.-L.; Shih C.-W.; Wei Y.-H.; Lu T.-X.; Chou C.-H.; Yen E.-Y.; Chang Y.-C.; Lin C.-C.; Chi Y.-C.; Yang W.-S.; FENG-CHIAO TSAI |
| 臺大學術典藏 |
2021-04-29T06:22:30Z |
Fibroblast Growth Factor Receptor Inhibitors Reduce Adipogenesis of Orbital Fibroblasts and Enhance Myofibroblastic Differentiation in Graves' Orbitopathy
|
SHYANG-RONG SHIH; Liao, Shu-Lang; Shih, Chih-Wei; Wei, Yi-Hsuan; Lu, Ting-Xuan; Chou, Chien-Hsiang; Yen, Er-Yen; Chang, Yi-Cheng; Lin, Chia-Chi; Chi, Yu-Chiao; Yang, Wei-Shiung; Tsai, Feng-Chiao |
| 臺大學術典藏 |
2019-11-21T12:25:33Z |
Fibroblast Growth Factor Receptor Inhibitors Reduce Adipogenesis of Orbital Fibroblasts and Enhance Myofibroblastic Differentiation in Graves’ Orbitopathy
|
Wei, Yi Hsuan; Yen, Er Yen; Shih, Chih Wei; Chang, Yi Cheng; Yang, Wei Shiung; Liao, Shu Lang; Chi, Yu Chiao;Shih, Shyang Rong;Lin, Chia Chi;Chou, Chien Hsiang;Tsai, Feng Chiao;Wei, Yi Hsuan;Shih, Chih Wei;Chang, Yi Cheng;Yang, Wei Shiung;Liao, Shu Lang;Lu, Ting Xuan;Yen, Er Yen; Tsai, Feng Chiao; Chou, Chien Hsiang; Lin, Chia Chi; Shih, Shyang Rong; Lu, Ting Xuan; Chi, Yu Chiao |
| 臺大學術典藏 |
2021-09-04T03:10:15Z |
Fibroblast Growth Factor Receptor Inhibitors Reduce Adipogenesis of Orbital Fibroblasts and Enhance Myofibroblastic Differentiation in Graves’ Orbitopathy
|
Shih S.-R.; SHU-LANG LIAO; Shih C.-W.; Wei Y.-H.; Lu T.-X.; Chou C.-H.; Yen E.-Y.; Chang Y.-C.; Lin C.-C.; Chi Y.-C.; Yang W.-S.; Tsai F.-C. |
| 臺大學術典藏 |
2022-03-10T05:59:20Z |
Fibroblast Growth Factor Receptor Inhibitors Reduce Adipogenesis of Orbital Fibroblasts and Enhance Myofibroblastic Differentiation in Graves’ Orbitopathy
|
Shih S.-R.; Liao S.-L.; Shih C.-W.; Wei Y.-H.; Lu T.-X.; Chou C.-H.; Yen E.-Y.; YI-CHENG CHANG; Lin C.-C.; Chi Y.-C.; Yang W.-S.; Tsai F.-C. |
顯示項目 428191-428200 / 2348609 (共234861頁)
<< < 42815 42816 42817 42818 42819 42820 42821 42822 42823 42824 > >>
每頁顯示[10|25|50]項目
|
